<DOC>
	<DOCNO>NCT03052283</DOCNO>
	<brief_summary>Development , validation evaluation new multimodal questionnaire ass quantify abdominal involvement patient inherited life shorten multi-organ disease Cystic fibrosis .</brief_summary>
	<brief_title>Symptom Score Assess Abdominal Involvement Patients With Cystic Fibrosis</brief_title>
	<detailed_description>Development multimodal questionnaire consider FDA guideline patient report outcome measure ( PROM ) - Evaluation reliability questionnaire examine internal consistency construct validity - Evaluation reproducibility questionnaire re-testing patient - Assessment cross-generational applicability questionnaire sub-scoring age group - Evaluation responsiveness score comparison age-matched healthy control - Assessment putative relationship abdominal symptom faecal inflammatory marker - Assessment applicability questionnaire CF center - Transfer JenAbdomen Score country language</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>CF cohort : Diagnosis CF determine sweat chloride &gt; 60 mEq/L and/or detection 2 disease cause CFTR mutation evidence organ involvement . Healthy control : Agematched CF cohort : Lacking ability cooperate patient /their family , respectively Healthy control : Other disease cause abdominal symptom ( alpha 1 antitrypsin deficiency , celiac disease , food allergy , gastroenteritis , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cystic fibrosis</keyword>
	<keyword>Abdomen</keyword>
	<keyword>Pancreas</keyword>
	<keyword>Liver</keyword>
	<keyword>Gut</keyword>
	<keyword>Symptom Score</keyword>
	<keyword>Patient report outcome measure ( PROM )</keyword>
</DOC>